Insulin medicines: Interventions
Interventions
Changes that would cut emissions or material use, by lever and life stage, with effect per unit, readiness, adoption, evidence and who acts
| Lever | Life stage | Change | Effect per unit | Readiness | Adoption | Who acts | Source |
|---|---|---|---|---|---|---|---|
| Efficiency | Use | Switch from once-daily to once-weekly basal insulin | Pens per patient per year fall from 22 to 5; for a sample of 100,000 patients the study reports 37 tons less plastic waste and 1.7 kilotons less carbon emissions a year, about 17 kg per patient per year (calculated within this one source) [14] | Deployed (a weekly insulin is on sale in India in 2026 [10]) | Not stated; modelled for France by authors from Novo Nordisk and the consultancy Putnam | Prescribers, makers, health systems | [14][10] |
| Design | Components design | Use a durable (reusable) pen with replaceable cartridges instead of a disposable pen | Carbon data Novo Nordisk gave an NHS team, for 1,000 people using pens for a year: 15,000 kg CO2e with disposable pens and 8,200 kg CO2e with durable pens lasting 5 years, so about 15 kg per person a year with disposable pens (calculated); the team did not know what the footprint included [15] | Deployed | Not stated | Makers, prescribers | [15] |
| Circularity | End of life | Take back used pens for recycling | Novo Nordisk says about 200,000 pens were returned in the UK by August 2023 and about two tonnes of plastic waste saved [16]; an NHS team calculates 0.0041347 kg CO2e per pen via PenCycle against 0.004128 in the black bag, so almost no carbon difference [15] | Deployed (national roll-out in October 2022) | About 3,700 UK community pharmacies registered, the company says | Makers, pharmacies, patients | [16][15] |
| Design | Supply chain | Allow insulin to be kept warm for longer before opening | WHO-prequalified human insulins by Novo Nordisk may be kept at up to 30 degrees C for four weeks before opening, which WHO says should ease use where refrigeration is limited [7] | Deployed | The four prequalified products | Makers, regulators | [7] |
as of 2026-11-13
Sources
- First human insulins prequalified World Health Organization, Prequalification of Medical Products, 2022, news item of 28 September 2022
- India 2030: Who Supplies the Next 10 Million? BioSpectrum India (Ankit Kankar), 2026, article of 1 November 2026
- Environmental Impact of Switching from Daily to Weekly Basal Insulin Administration in France ISPOR Europe 2024 abstract EE212 (Bellier L, Antier C, Soggiu M, Virely N, Laporte L, Sivignon M, Kind B; affiliations Putnam, Paris, and Novo Nordisk, Paris), Value in Health 27(12) S2, 2024
- Improving the environmental impact of patients with diabetes and on insulin. Centre for Sustainable Healthcare SusQI project report template, completed by a community diabetes team in North Warwickshire, 2023, Aim 1 (Novo Nordisk carbon data for pens) and Aim 2 (PenCycle, the team's own per-pen calculation); date of report 14 July 2023
- Patients return 200,000 injection pens through recycling scheme The Pharmaceutical Journal (David Lipanovic), 2023, article of 15 August 2023